For semaglutide, while the core patent (protecting the molecule itself) expires in 2026, Novo Nordisk has likely filed secondary patents on aspects like formulations, dosage regimens, or delivery mechanismspotentially extending protection into the 2030s
M10, mangosteen garcinia ( Garcinia mangostana )
Individuals with obesity, compared to those with a healthy weight, have increased risk for several serious diseases and conditions, including hypertension, asthma, heart disease, stroke, type 2 diabetes, many cancers, breathing difficulty, and joint issues
Taking the medicine with smaller meals and drinking plenty of fluids can sometimes help
The odds ratio and its 95% confidence interval were calculated for every independent parameter associated with L-carnitine treatment